Related Experiment Video
Updated: Feb 27, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Incidence and Prognostic Implications of Late Bleeding After Myocardial Infarction or Unstable Angina According to
Miriam Brinkert1, Danielle A Southern2, Matthew T James3
1Heart Center Lucerne, Luzerner Kantonsspital, Lucerne, Switzerland.
Insights
Patients undergoing revascularization for acute coronary syndrome (ACS) have a low risk of late bleeding. However, these bleeding events are linked to increased mortality, highlighting the importance of monitoring post-procedure.
Area of Science:
- Cardiology
- Health Services Research
- Clinical Outcomes
Background:
- Bleeding complications after coronary revascularization increase mortality.
- Limited data exist on the subsequent bleeding risk in patients with acute coronary syndrome (ACS).
- This study assesses late bleeding events in ACS patients based on treatment allocation.
Purpose of the Study:
- To evaluate the incidence of late bleeding events.
- To compare bleeding risk among different treatment strategies for ACS.
- To determine the association between late bleeding and mortality.
Main Methods:
- Utilized administrative data from the Canadian Institute for Health Information.
- Identified a cohort of 31,941 patients hospitalized with ACS.
- Calculated crude and adjusted odds ratios for bleeding up to 1 year post-discharge.
Main Results:
- Percutaneous coronary intervention (PCI) was associated with lower odds of late bleeding compared to medical management (OR, 0.76).
- The overall incidence of readmission with bleeding was low across treatment groups (1.8%–3.8%).
- Late bleeding within the first year after ACS significantly increased mortality risk (OR, 4.96).
Conclusions:
- Revascularization procedures for ACS are associated with a relatively low risk of late bleeding.
- Late bleeding events following ACS hospitalization are a significant risk factor for mortality.
- Careful monitoring for bleeding is crucial in ACS patients, particularly after revascularization.
Background:
Bleeding complications accompanying coronary revascularization are associated with increased mortality; however, few data are available on subsequent bleeding risk. We used administrative data to assess the incidence of late bleeding events in patients with acute coronary syndrome (ACS) according to treatment allocation.
Methods:
The cohort and bleeding events were identified through the Canadian Institute for Health Information discharge abstract database. Crude and adjusted odds ratios (ORs) were calculated for index and postindex admission bleeding up to 1 year after discharge.
Results:
Of 31,941 patients hospitalized with ACS, 7681 (32.4%) patients were treated with medication alone, 3728 (15.2%) underwent angiography without intervention, and 13,075 (53.4%) underwent percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The overall incidence of readmission with bleeding based on administrative codes was low (3.8% for medically treated patients, 2.8% for patients who underwent angiography alone, 2.6% for patients who underwent CABG, and 1.8% for patients who underwent PCI; P < 0.0001). Bleeding codes were mainly gastrointestinal bleeding (52%), but 7.8% were intracranial episodes of bleeding. Patients who received PCI had significantly lower odds of late bleeding compared with medically treated patients (OR, 0.76; 95% CI, 0.62-0.94). Late bleeding during the first year after ACS was associated with mortality (OR, 4.96; 95% CI, 2.47-9.93).
Conclusions:
Patients who underwent revascularization procedures had a relatively low risk for late bleeding events after a hospitalization for ACS. Late bleeding events were associated with an increased risk of death.
More Related Videos
Related Concept Videos
Angina II: Classification
Angina IV: Management
Angina V: Nursing Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

